Alessandra Cipriano

611 total citations
29 papers, 443 citations indexed

About

Alessandra Cipriano is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Alessandra Cipriano has authored 29 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Physiology. Recurrent topics in Alessandra Cipriano's work include Opioid Use Disorder Treatment (10 papers), Pain Management and Opioid Use (6 papers) and Pain Mechanisms and Treatments (6 papers). Alessandra Cipriano is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Pain Management and Opioid Use (6 papers) and Pain Mechanisms and Treatments (6 papers). Alessandra Cipriano collaborates with scholars based in United States, Italy and Japan. Alessandra Cipriano's co-authors include Gianluca Sbardella, Alessandra Feoli, Ciro Milite, Sabrina Castellano, Monica Viviano, Stephen Harris, Ram P. Kapil, Salvatore V. Colucci, Manjunath S. Shet and Alessio Ciulli and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and SLEEP.

In The Last Decade

Alessandra Cipriano

28 papers receiving 436 citations

Peers

Countries citing papers authored by Alessandra Cipriano

Since Specialization

Citations

This map shows the geographic impact of Alessandra Cipriano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Cipriano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Cipriano more than expected).

Fields of papers citing papers by Alessandra Cipriano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Cipriano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Cipriano. The network helps show where Alessandra Cipriano may publish in the future.

Co-authorship network of co-authors of Alessandra Cipriano

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Cipriano. A scholar is included among the top collaborators of Alessandra Cipriano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Cipriano. Alessandra Cipriano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto‐Injector Versus Intranasal Naloxone 2025 ·The Journal of Clinical Pharmacology ·Alessandra Cipriano, Ellie He, Manjunath S. Shet, Glen Apseloff, Stephen Harris	0
2	Prodrug Approach to Exploit (S)‐Alanine Amide as Arginine Mimic Moiety in the Development of Protein Arginine Methyltransferase 4 Inhibitors 2024 ·ChemMedChem ·Ciro Milite, (unknown), (unknown), (unknown), Monica Viviano, (unknown), (unknown), Alessandra Feoli, Alessandra Cipriano, Maria Giovanna Chini, Sabrina Castellano, Giuseppe Bifulco, Gianluca Sbardella	2
3	Successes and challenges in the development of BD1-selective BET inhibitors: a patent review 2024 ·Expert Opinion on Therapeutic Patents ·Monica Viviano, Alessandra Cipriano, (unknown), Alessandra Feoli, Sabrina Castellano, Gianluca Sbardella, Antonello Mai, Ciro Milite, Dante Rotili	2
4	Evaluation of sunobinop for next-day residual effects in healthy participants 2024 ·Frontiers in Pharmacology ·Alessandra Cipriano, Ram P. Kapil, Mingyan Zhou, Manjunath S. Shet, Stephen Harris, Glen Apseloff, Garth T. Whiteside	3
5	Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone 2024 ·The Journal of Clinical Pharmacology ·Alessandra Cipriano, Glen Apseloff, Ram P. Kapil, Ellie He, Manjunath S. Shet, Stephen Harris	2
6	Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 2023 ·Journal of Medicinal Chemistry ·Alessandra Feoli, (unknown), Alessandra Cipriano, Ciro Milite, Lei Shen, Zhihao Wang, Andrea Hadjikyriacou, (unknown), (unknown), Monica Viviano, (unknown), Elva Morretta, Maria Chiara Monti, Yanzhong Yang, Steven Clarke, Sandro Cosconati, Sabrina Castellano, Gianluca Sbardella	9
7	NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors 2023 ·Journal of Medicinal Chemistry ·Alessandra Cipriano, Monica Viviano, Alessandra Feoli, Ciro Milite, (unknown), Sabrina Castellano, Gianluca Sbardella	85
8	A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 2023 ·Archiv der Pharmazie ·Greta Donati, Monica Viviano, (unknown), Alessandra Cipriano, (unknown), Jussara Amato, Stefano Tomassi, Diego Brancaccio, (unknown), Francesco Saverio Di Leva, Daniela Arosio, Pierfausto Seneci, Sabrina Taliani, Katarzyna Magiera‐Mularz, Bogdan Musielak, Łukasz Skalniak, Tad A. Holak, Sabrina Castellano, Valeria La Pietra, Luciana Marinelli	2
9	The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomnia 2023 ·Journal of Clinical Investigation ·Garth T. Whiteside, Donald J. Kyle, Ram P. Kapil, Alessandra Cipriano, Ellie He, Mingyan Zhou, Manjunath S. Shet, Michele Hummel, (unknown), Kazuya Fukumura, Yoshiyuki Matsuo, Masahiro Uehira, (unknown), Nozomi Takai, S.K. Willsie, Stephen Harris	7
10	Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain 2022 ·ChemMedChem ·Alessandra Cipriano, Ciro Milite, Alessandra Feoli, Monica Viviano, Giacomo Pepe, Pietro Campiglia, (unknown), S. Picaud, Satomi Imaide, Nikolai Makukhin, P. Filippakopoulos, Alessio Ciulli, Sabrina Castellano, Gianluca Sbardella	9
11	Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach 2022 ·Journal of Medicinal Chemistry ·(unknown), Ciro Milite, (unknown), Vincent Cura, L. Bonnefond, N. Troffer-Charlier, Alessandra Feoli, (unknown), Yalong Wang, Alessandra Cipriano, Monica Viviano, (unknown), J. Cavarelli, Sabrina Castellano, Gianluca Sbardella	18
12	Targeting epigenetic reader domains by chemical biology 2020 ·Current Opinion in Chemical Biology ·Alessandra Cipriano, Gianluca Sbardella, Alessio Ciulli	20
13	Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies 2019 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Ciro Milite, Giorgio Amendola, Alessio Nocentini, Silvia Bua, Alessandra Cipriano, Elisabetta Barresi, Alessandra Feoli, Ettore Novellino, Federico Da Settimo, Claudiu T. Supuran, Sabrina Castellano, Sandro Cosconati, Sabrina Taliani	32
14	Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users 2015 ·Pain Medicine ·Stephen Harris, Alessandra Cipriano, Salvatore V. Colucci, Ram P. Kapil, Pierre A. Geoffroy, (unknown), Naama Levy‐Cooperman	21
15	Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of Hydrocodone After Coadministration With a Single-entity, Once-daily, Extended-release Hydrocodone Tablet 2015 ·Clinical Therapeutics ·Ram P. Kapil, (unknown), Alessandra Cipriano, (unknown), Manjunath S. Shet, (unknown), Stephen Harris	12
16	Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties 2015 ·Clinical Therapeutics ·Ram P. Kapil, Alessandra Cipriano, Warren Wen, (unknown), Ellie He, Salvatore V. Colucci, Stephen Harris	4
17	Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels 2012 ·Journal of Pain and Symptom Management ·Ram P. Kapil, Alessandra Cipriano, (unknown), (unknown), Manjunath S. Shet, Salvatore V. Colucci, Glen Apseloff, (unknown), Stephen Harris	30
18	Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System 2012 ·Clinical Drug Investigation ·Ram P. Kapil, Alessandra Cipriano, (unknown), (unknown), (unknown), Manjunath S. Shet, Salvatore V. Colucci, Robert J. Noveck, Stephen Harris	28
19	Clinical Pharmacology and Pharmacokinetics of Once‐Daily Hydromorphone Hydrochloride Extended‐Release Capsules 2005 ·The Journal of Clinical Pharmacology ·(unknown), Stephen Harris, Ahmed El‐Tahtawy, Danlin Wu, Alessandra Cipriano	14
20	Comparative Pharmacokinetics and Bioavailability of Nitroglycerin and its Metabolites from Transderm‐Nitro, Nitrodisc, and Nitro‐Dur II Systems Using a Stable‐Isotope Technique 1995 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), John Morgan, (unknown), Alessandra Cipriano, Keith K. H. Chan, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact